Stay updated on Extension Study of Upadacitinib in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Extension Study of Upadacitinib in Atopic Dermatitis Clinical Trial page.

Latest updates to the Extension Study of Upadacitinib in Atopic Dermatitis Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe study record now indicates that recruitment is closed and it no longer seeks participants. This clarifies the current enrollment status for users reviewing the study details.SummaryDifference0.2%

- Check17 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5, signaling a minor version bump on the page. This update appears to be maintenance rather than a modification to study content or essential site functionality.SummaryDifference0.0%

- Check39 days agoChange DetectedThe page shows a new revision tag, upgrading from v3.5.3 to v3.5.4. This update does not affect the study details or data presented on the page.SummaryDifference0.0%

- Check60 days agoChange DetectedThe page’s interface/version footer was updated from “v3.5.2” to “v3.5.3,” reflecting a change to the ClinicalTrials.gov release rather than study content.SummaryDifference0.0%

- Check67 days agoChange DetectedAdded Revision: v3.5.2; removed Revision: v3.5.0.SummaryDifference0.0%

- Check96 days agoChange DetectedThe page now displays Revision: v3.5.0, replacing the previous Revision: v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Extension Study of Upadacitinib in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Extension Study of Upadacitinib in Atopic Dermatitis Clinical Trial page.